Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 704721, 8 pages
http://dx.doi.org/10.1093/ecam/nep147
Original Article

In Vitro Activity of 2-methoxy-1,4-naphthoquinone and Stigmasta-7,22-diene-3β-ol from Impatiens balsamina L. against Multiple Antibiotic-Resistant Helicobacter pylori

1Department of Food Science and Biotechnology, National Chung Hsing University, Taichung, Taiwan
2Division of Gastroenterology, Department of Internal Medicine, Kaoshing Medical University, Kaohsiung, Taiwan
3Graduate Institute of Healthcare Administration, College of Health Sciences, Kaoshing Medical University, Kaohsiung, Taiwan
4Faculty of Medicinal and Applied Chemistry, Kaoshing Medical University, Kaohsiung, Taiwan
5Department of Chemistry, National Chung Hsing University, Taichung, Taiwan

Received 22 April 2009; Accepted 30 August 2009

Copyright © 2011 Yuan-Chuen Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Forman, D. G. Newekk, F. Fullerton et al., “Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation,” British Medical Journal, vol. 302, pp. 1302–1305, 1991. View at Google Scholar
  2. J. A. Worrel and S. C. Stoner, “Eradication of Helicobacter pylori,” Medical Update for Psychiatrists, vol. 3, no. 4, pp. 99–104, 1998. View at Publisher · View at Google Scholar
  3. Y. J. Debets-Ossenkopp, A. J. Herscheid, R. G. J. Pot, E. J. Kuipers, J. G. Kusters, and C. M. J. E. Vandenbroucke-Grauls, “Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands,” Journal of Antimicrobial Chemotherapy, vol. 43, no. 4, pp. 511–515, 1999. View at Google Scholar
  4. I. Kobayashi, K. Murakami, M. Kato et al., “Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005,” Journal of Clinical Microbiology, vol. 45, no. 12, pp. 4006–4010, 2007. View at Publisher · View at Google Scholar · View at PubMed
  5. H. Oku and K. Ishiguro, “Antipruritic and antidermatitic effect of extract and compounds of Impatients balsamina L. in atopic dermatitis model NC mice,” Phytotherapy Research, vol. 15, pp. 506–510, 2001. View at Google Scholar
  6. D. G. Lee, S. Y. Shin, D.-H. Kim et al., “Antifungal mechanism of a cysteine-rich antimicrobial peptide, Ib-AMP1, from Impatiens balsamina against Candida albicans,” Biotechnology Letters, vol. 21, no. 12, pp. 1047–1050, 1999. View at Publisher · View at Google Scholar
  7. J. E. Little, T. J. Sproston, and M. W. Foote, “Isolation and antifungal action of naturally occurring 2-methoxy-1,4-naphthoquinone,” Journal of Biological Chemistry, vol. 174, pp. 335–342, 1948. View at Google Scholar
  8. P. Panichayupakaranant, H. Noguchi, W. De-Eknamkul, and U. Sankawa, “Naphthoquinones and coumarins from Impatiens balsamina root cultures,” Phytochemistry, vol. 40, no. 4, pp. 1141–1143, 1995. View at Publisher · View at Google Scholar
  9. A. Hasan and M. N. Tahir, “Flavonoids from the leaves of Impatiens bicolor,” Turkish Journal of Chemistry, vol. 29, no. 1, pp. 65–70, 2005. View at Google Scholar
  10. A. Lobstein, X. Brenne, E. Feist, N. Metz, B. Weniger, and R. Anton, “Quantitative determination of naphthoquinones of Impatiens species,” Phytochemical Analysis, vol. 12, no. 3, pp. 202–205, 2001. View at Publisher · View at Google Scholar · View at PubMed
  11. S. Rodriguez, J.-L. Wolfender, E. Hakizamungu, and K. Hostettmann, “An antifungal naphthoquinone, xanthones and secoiridoids from Swertia calycina,” Planta Medica, vol. 61, no. 4, pp. 362–364, 1995. View at Publisher · View at Google Scholar · View at PubMed
  12. H. Oku, T. Kato, and K. Ishiguro, “Antipruritic effects of 1,4-naphthoquinones and related compounds,” Biological & Pharmaceutical Bulletin, vol. 25, no. 1, pp. 137–139, 2002. View at Google Scholar
  13. J.-C. Lien, L.-J. Huang, J.-P. Wang, C.-M. Teng, K.-H. Lee, and S.-C. Kuo, “Synthesis and antiplatelet, antiinflammatory and antiallergic activities of 2,3-disubstituted 1,4-naphthoquinones,” Chemical and Pharmaceutical Bulletin, vol. 44, no. 6, pp. 1181–1187, 1996. View at Google Scholar
  14. Z.-S. Ding, F.-S. Jiang, N.-P. Chen, G.-Y. Lv, and C.-G. Zhu, “Isolation and identification of an anti-tumor component from leaves of Impatiens balsamina,” Molecules, vol. 13, no. 2, pp. 220–229, 2008. View at Publisher · View at Google Scholar
  15. E. Blignaut, L. L. Patton, W. Nittayananta, V. Ramirez-Amador, K. Ranganathan, and A. Chattopadhyay, “(A3) HIV phenotypes, oral lesions, and management of HIV-related disease,” Advances in Dental Research, vol. 19, no. 1, pp. 122–129, 2006. View at Google Scholar
  16. X. Yang, D. K. Summerhurst, S. F. Koval, C. Ficker, M. L. Smith, and M. A. Bernards, “Isolation of an antimicrobial compound from Impatiens balsamina L. using bioassay-guided fractionation,” Phytotherapy Research, vol. 15, no. 8, pp. 676–680, 2001. View at Publisher · View at Google Scholar · View at PubMed
  17. L. S. Huang and C. Grunwald, “Effect of light on sterol changes in Medicago sativa,” Plant Physiology, vol. 88, pp. 1403–1406, 1988. View at Google Scholar
  18. S. Dan, S. S. Dan, P. Mukhopadhyay, and M. K. Mukherjee, “Chemical investigation of some Annonaceae species,” International Journal of Crude Drug Research, vol. 23, pp. 73–76, 1985. View at Google Scholar
  19. M. J. Salvador, O. L. A. D. Zucchi, R. C. Candido, I. Y. Ito, and D. A. Dias, “In vitro antimicrobial activity of crude extracts and isolated constituents of Alternanthera maritima,” Pharmaceutical Biology, vol. 42, no. 2, pp. 138–148, 2004. View at Publisher · View at Google Scholar
  20. G.-C. Jeon, M.-S. Park, D.-Y. Yoon, C.-H. Shin, H.-S. Sin, and S.-J. Um, “Antitumor activity of spinasterol isolated from Pueraria roots,” Experimental and Molecular Medicine, vol. 37, no. 2, pp. 111–120, 2006. View at Google Scholar
  21. Y.-C. Wang, D.-C. Wu, J.-J. Liao, C.-H. Wu, W.-Y. Li, and B.-C. Weng, “In vitro activity of Impatiens balsamina L. against multiple antibiotic-resistant Helicobacter pylori,” American Journal of Chinese Medicine, vol. 37, no. 4, pp. 713–722, 2009. View at Publisher · View at Google Scholar
  22. Y.-C. Wang and T.-L. Huang, “Anti-Helicobacter pylori activity of Plumbago zeylanica L,” FEMS Immunology and Medical Microbiology, vol. 43, no. 3, pp. 407–412, 2005. View at Publisher · View at Google Scholar · View at PubMed
  23. T. Rüegg, A. I. Calderón, E. F. Queiroz et al., “3-Farnesyl-2-hydroxybenzoic acid is a new anti-Helicobacter pylori compound from Piper multiplinervium,” Journal of Ethnopharmacology, vol. 103, no. 3, pp. 461–467, 2006. View at Publisher · View at Google Scholar · View at PubMed
  24. O. Ustün, B. Ozçelik, Y. Akyön, U. Abbasoglu, and E. Yesilada, “Flavonoids with anti-Helicobacter pylori activity from Cistus laurifolius leaves,” Journal of Ethnopharmacology, vol. 108, no. 3, pp. 457–461, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. M. D. Leo, N. D. Tommasi, R. Sanogo et al., “Triterpenoid saponins from Pteleopsis suberosa stem bark,” Phytochemistry, vol. 67, no. 24, pp. 2623–2629, 2006. View at Publisher · View at Google Scholar · View at PubMed
  26. B.-S. Park, H.-K. Lee, S.-E. Lee et al., “Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori,” Journal of Ethnopharmacology, vol. 105, no. 1-2, pp. 255–262, 2006. View at Publisher · View at Google Scholar · View at PubMed
  27. E. A. O'Gara, D. J. Hill, and D. J. Maslin, “Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori,” Applied and Environmental Microbiology, vol. 66, no. 5, pp. 2269–2273, 2000. View at Publisher · View at Google Scholar
  28. R. Munday, “Autooxidation of naphthaquinones: effect of pH, naphthoquinones and superoxide dimutase,” Free Radical Research, vol. 32, pp. 245–253, 2000. View at Google Scholar
  29. A. M. Osman and P. C. M. van Noort, “Evidence for redox cycling of lawsone (2-hydroxy-1,4-naphthoquinone) in the presence of the hypoxanthine/xanthine oxidase system,” Journal of Applied Toxicology, vol. 23, no. 4, pp. 209–212, 2003. View at Publisher · View at Google Scholar · View at PubMed
  30. D. C. McMillan, S. D. Sarvete, J. E. Oatis Jr., and D. J. Jollow, “Role of oxidant stress in lawsone-induced hemolytic anemia,” Toxicological Sciences, vol. 82, no. 2, pp. 647–655, 2004. View at Publisher · View at Google Scholar · View at PubMed
  31. V. De Francesco, M. Margiotta, A. Zullo et al., “Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 4, pp. 783–785, 2007. View at Publisher · View at Google Scholar · View at PubMed
  32. E. Rozynek, K. Dzierzanowska-Fangrat, D. Celińska-Cedro, P. Joźźwiak, K. Madaliński, and D. Dzierzanowska, “Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children,” Acta Microbiologica Polonica, vol. 51, no. 3, pp. 255–263, 2002. View at Google Scholar
  33. H.-X. Xia, M. Buckley, C. T. Keane, and C. A. O'Morain, “Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro,” Journal of Antimicrobial Chemotherapy, vol. 37, no. 3, pp. 473–481, 1996. View at Publisher · View at Google Scholar
  34. P. O. Erah, A. F. Goddard, D. A. Barrett, P. N. Shaw, and R. C. Spiller, “The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection,” Journal of Antimicrobial Chemotherapy, vol. 39, no. 1, pp. 5–12, 1997. View at Publisher · View at Google Scholar